Home › Sjogren's Syndrome › Missouri
Sjogren's Syndrome clinical trials in Missouri
3 studies for Sjogren's Syndrome are looking for participants at sites in Missouri.
Cities in Missouri
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- and 6 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Kansas City Physician Partners, Kansas City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Kansas City Physician Partners-8350 N Saint Clair Ave, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.